Abstract:
SARS-CoV-2 virus has led to an unprecedented amount of tracheal stenosis. Rigid bronchoscopy can serve as a curative measure or bridge therapy to tracheal resection. We also briefly discuss the pathophysiology of tracheal stenosis from prolonged intubation and SARS-CoV-2 virus. This should be differentiated from other forms of airway obstruction such as tracheobronchomalacia which would be considered a pseudo-tracheal stenotic disease. The aim of this study is to evaluate stenosis that is unable to be improved with positive airway pressure or \"PAP\" therapies and required stenting and/or subsequent tracheal resection. By performing Rigid Bronchoscopy and subsequent stenting of airways, we demonstrated outcomes for long term airway patency regarding patients who were intubated secondary to the SARS-CoV-2 virus. We demonstrate superb outcomes in a consecutive case series of 6 patients managed with rigid bronchoscopy, airway stent and tracheal resection. The patients were all managed from a pulmonary perspective by the physicians mentioned in this study.
摘要:
SARS-CoV-2病毒导致了前所未有的气管狭窄。刚性支气管镜检查可作为气管切除的治疗措施或桥接疗法。我们还简要讨论了长时间插管和SARS-CoV-2病毒引起的气管狭窄的病理生理学。应将其与其他形式的气道阻塞区分开,例如被认为是假性气管狭窄疾病的气管支气管软化症。这项研究的目的是评估气道正压通气或“PAP”疗法以及所需的支架置入和/或随后的气管切除术无法改善的狭窄。通过进行刚性支气管镜检查和随后的气道支架置入术,我们证明了SARS-CoV-2病毒继发插管患者的长期气道通畅结局.我们在连续病例系列中展示了出色的结果,其中6例患者接受了硬质支气管镜检查,气道支架和气管切除术。所有患者均由本研究中提到的医生从肺部角度进行管理。